The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation

Therapeutics that block tumor necrosis factor (TNF), and thus activation of TNF receptor 1 (TNFR1) and TNFR2, are clinically used to treat inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. However, TNFR1 and TNFR2 work antithetically to balance immune resp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Richter, Fabian, Williams, Sarah K., John, Katharina, Huber, Carina, Vaslin, Camille, Zanker, Henri, Fairless, Richard, Pichi, Kira, Marhenke, Silke, Vogel, Arndt, Dhaen, Marie-Ann, Herrmann, Stefanie, Herrmann, Andreas, Pfizenmaier, Klaus, Bantel, Heike, Diem, Ricarda, Kontermann, Roland E., Fischer, Roman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8294390/
https://ncbi.nlm.nih.gov/pubmed/34305946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.705485
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller